Ledger.Open graph →
SEC Form D · filed June 27, 2024

Coeptis Therapeutics Holdings, Inc

Offering
$10.0M
Sold
$4.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WEXFORD, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

David Mehalick · Wexford, PAExec · DirectorChristopher M. Cochran · Wexford, PADirectorGene M. Salkind · Wexford, PADirectorChristine Sheehy · Wexford, PAExecPhilippe M. Deschamps · Wexford, PADirectorBrian Cogley · Wexford, PAExecDaniel Yerace · Wexford, PAExec · DirectorDavid Mehalick · Wexford, PAExec · DirectorTara M. Desilva · Wexford, PADirectorColleen Delaney · Seattle, WAExecChristopher Calise · New York, NYDirectorJohn Fitzpatrick · West Hills, CAExec · DirectorChristopher M. Cochran · Wexford, PADirectorGene M. Salkind · Wexford, PADirectorColleen Delaney · Seattle, WAExecChristine Sheehy · Wexford, PAExecTara M. Desilva · Wexford, PADirectorPhilippe M. Deschamps · Wexford, PADirectorBrian Cogley · Wexford, PAExecDaniel Yerace · Wexford, PAExec · DirectorChristopher Calise · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗